Dr. Beatrice Setnik

Dr. Setnik joined Altasciences in 2019. In her previous roles as Vice President of Scientific & Medical Affairs at INC Research/Syneos Health (Early Phase), Senior Director, Clinical Sciences (King Pharmaceuticals and Pfizer, Inc), and Research Scientist (formerly Ventana / Decisionline Clinical Research) she has accumulated impressive experience in early phase clinical trials, regulatory filing, lifecycle management, and strategic initiatives in business development and clinical drug development. Dr. Setnik is also an Adjunct Professor at the University of Toronto, Department of Pharmacology and Toxicology and the Managing Director lead of the Cross Company Abuse Liability Council and chair of the Clinical Pharmacology Community of the Drug Information Association (DIA). She is also an active member and speaker at various congresses including the College on Problems of Drug Dependence; and is actively engaged in many aspects of abuse potential assessment including development of patient reported outcome instruments and contributing to post-marketing surveillance studies.

PhD in Pharmacology and the Collaborative Program in Neuroscience